Nasal spray composition

Abstract

The present invention relates to a pharmaceutical composition in the form of an aqueous suspension suitable for nasal administration. The composition comprises mometasone furoate or a hydrate thereof, olopatadine or a pharmaceutically acceptable salt thereof (e.g., olopatadine hydrochloride), and a means for controlling the obstruction of an actuator and / or immersion tube in a spray apparatus from which the composition is administered. The composition is suitable for providing continuous administration, for example, for at least 5 days without clogging the actuator or immersion tube of a nasal spray device. The present invention also relates to a process for preparing the composition in the form of an aqueous suspension.